These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
R
|
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
£
|
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
|
|
|
|
Delaware
|
|
20-3934755
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(IRS Employer
Identification No.)
|
|
|
|
|
|
27442 Portola Parkway, Suite 200
|
|
|
|
Foothill Ranch, California
|
|
92610
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
Large accelerated filer
|
£
|
|
Accelerated filer
|
Q
|
|
|
|
|
|
|
|
Non-accelerated filer
|
£
|
(do not check if smaller reporting company)
|
Smaller reporting company
|
£
|
|
|
|
|
|
Page
Number
|
|
Part I.
|
|
|
|
Item 1.
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
Item 2.
|
||
|
Item 3.
|
||
|
Item 4.
|
||
|
Part II.
|
|
|
|
Item 1.
|
||
|
Item 1A.
|
||
|
Item 2.
|
||
|
Item 3.
|
||
|
Item 4.
|
||
|
Item 5.
|
||
|
Item 6.
|
||
|
|
||
|
|
||
|
|
March 31, 2011
|
|
December 31, 2010
|
||||
|
|
(Unaudited)
|
|
|
||||
|
ASSETS
|
|
|
|
||||
|
Current assets:
|
|
|
|
||||
|
Cash and cash equivalents
|
$
|
940
|
|
|
$
|
4,192
|
|
|
Accounts receivable, less allowance for doubtful accounts of $17,030 and $17,710 at March 31, 2011 and December 31, 2010, respectively
|
107,904
|
|
|
98,777
|
|
||
|
Deferred income taxes
|
12,152
|
|
|
20,419
|
|
||
|
Prepaid expenses
|
9,137
|
|
|
9,618
|
|
||
|
Other current assets
|
17,522
|
|
|
15,819
|
|
||
|
Total current assets
|
147,655
|
|
|
148,825
|
|
||
|
Property and equipment, less accumulated depreciation of $81,787 and $76,017 at March 31, 2011 and December 31, 2010, respectively
|
383,429
|
|
|
387,322
|
|
||
|
Other assets:
|
|
|
|
||||
|
Notes receivable
|
6,445
|
|
|
5,877
|
|
||
|
Deferred financing costs, net
|
12,339
|
|
|
13,165
|
|
||
|
Goodwill
|
332,724
|
|
|
332,724
|
|
||
|
Intangible assets, less accumulated amortization of $6,206 and $15,646 at March 31, 2011 and December 31, 2010, respectively
|
25,446
|
|
|
25,341
|
|
||
|
Other assets
|
33,073
|
|
|
31,036
|
|
||
|
Total other assets
|
410,027
|
|
|
408,143
|
|
||
|
Total assets
|
$
|
941,111
|
|
|
$
|
944,290
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
||||
|
Current liabilities:
|
|
|
|
||||
|
Accounts payable and accrued liabilities
|
$
|
48,002
|
|
|
$
|
50,898
|
|
|
Employee compensation and benefits
|
34,621
|
|
|
39,400
|
|
||
|
Current portion of long-term debt and capital leases
|
6,689
|
|
|
5,742
|
|
||
|
Total current liabilities
|
89,312
|
|
|
96,040
|
|
||
|
Long-term liabilities:
|
|
|
|
||||
|
Insurance liability risks
|
33,546
|
|
|
32,034
|
|
||
|
Deferred income taxes
|
9,831
|
|
|
8,431
|
|
||
|
Other long-term liabilities
|
16,923
|
|
|
15,984
|
|
||
|
Long-term debt and capital leases, less current portion
|
501,430
|
|
|
514,221
|
|
||
|
Total liabilities
|
651,042
|
|
|
666,710
|
|
||
|
Stockholders’ equity:
|
|
|
|
||||
|
Class A common stock, 175,000 shares authorized, $0.001 par value per share; 21,046 and 20,780 at March 31, 2011 and December 31, 2010, respectively
|
21
|
|
|
21
|
|
||
|
Class B common stock, 30,000 shares authorized, $0.001 par value per share; 16,990 and 16,994 at March 31, 2011 and December 31, 2010, respectively
|
17
|
|
|
17
|
|
||
|
Additional paid-in-capital
|
369,216
|
|
|
368,582
|
|
||
|
Accumulated deficit
|
(78,978
|
)
|
|
(90,822
|
)
|
||
|
Accumulated other comprehensive loss
|
(207
|
)
|
|
(218
|
)
|
||
|
Total stockholders’ equity
|
290,069
|
|
|
277,580
|
|
||
|
Total liabilities and stockholders’ equity
|
$
|
941,111
|
|
|
$
|
944,290
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2011
|
|
2010
|
||||
|
Revenue
|
$
|
222,578
|
|
|
$
|
189,319
|
|
|
Expenses:
|
|
|
|
||||
|
Cost of services (exclusive of rent cost of revenue and depreciation and amortization shown below)
|
175,461
|
|
|
151,705
|
|
||
|
Rent cost of revenue
|
4,570
|
|
|
4,581
|
|
||
|
General and administrative
|
6,893
|
|
|
6,351
|
|
||
|
Depreciation and amortization
|
6,145
|
|
|
5,944
|
|
||
|
|
193,069
|
|
|
168,581
|
|
||
|
Other income (expenses):
|
|
|
|
||||
|
Interest expense
|
(9,946
|
)
|
|
(7,284
|
)
|
||
|
Interest income
|
175
|
|
|
228
|
|
||
|
Other expense
|
(324
|
)
|
|
(4
|
)
|
||
|
Equity in earnings of joint venture
|
554
|
|
|
797
|
|
||
|
Total other expenses, net
|
(9,541
|
)
|
|
(6,263
|
)
|
||
|
Income before provision for income taxes
|
19,968
|
|
|
14,475
|
|
||
|
Provision for income taxes
|
8,124
|
|
|
5,594
|
|
||
|
Net income
|
$
|
11,844
|
|
|
$
|
8,881
|
|
|
Earnings per share, basic:
|
|
|
|
||||
|
Earnings per share
|
$
|
0.32
|
|
|
$
|
0.24
|
|
|
Earnings per share, diluted:
|
|
|
|
||||
|
Earnings per share
|
$
|
0.32
|
|
|
$
|
0.24
|
|
|
Weighted-average common shares outstanding, basic
|
37,079
|
|
|
36,962
|
|
||
|
Weighted-average common shares outstanding, diluted
|
37,326
|
|
|
37,037
|
|
||
|
|
Three Months Ended
March 31, |
||||||
|
|
2011
|
|
2010
|
||||
|
Cash Flows from Operating Activities
|
|
|
|
||||
|
Net income
|
11,844
|
|
|
8,881
|
|
||
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
||||
|
Depreciation and amortization
|
6,145
|
|
|
5,944
|
|
||
|
Provision for doubtful accounts
|
2,457
|
|
|
2,595
|
|
||
|
Non-cash stock-based compensation
|
998
|
|
|
360
|
|
||
|
Excess tax benefits from stock-based payment arrangements
|
(295
|
)
|
|
—
|
|
||
|
Disposal of property and equipment
|
290
|
|
|
—
|
|
||
|
Amortization of deferred financing costs
|
826
|
|
|
1,421
|
|
||
|
Deferred income taxes
|
10,077
|
|
|
484
|
|
||
|
Amortization of discount and accretion on debt
|
140
|
|
|
27
|
|
||
|
Changes in operating assets and liabilities:
|
|
|
|
||||
|
Accounts receivable
|
(13,114
|
)
|
|
(4,035
|
)
|
||
|
Payments on notes receivable
|
959
|
|
|
943
|
|
||
|
Other current and non-current assets
|
(1,007
|
)
|
|
(597
|
)
|
||
|
Accounts payable and accrued liabilities
|
(3,482
|
)
|
|
2,799
|
|
||
|
Employee compensation and benefits
|
(5,348
|
)
|
|
(879
|
)
|
||
|
Insurance liability risks
|
538
|
|
|
143
|
|
||
|
Other long-term liabilities
|
847
|
|
|
52
|
|
||
|
Net cash provided by operating activities
|
11,875
|
|
|
18,138
|
|
||
|
Cash Flows from Investing Activities
|
|
|
|
||||
|
Additions to property and equipment
|
(2,567
|
)
|
|
(9,698
|
)
|
||
|
Acquisition of home health licenses
|
(350
|
)
|
|
—
|
|
||
|
Proceeds from sale of property and equipment
|
400
|
|
|
—
|
|
||
|
Net cash used in investing activities
|
(2,517
|
)
|
|
(9,698
|
)
|
||
|
Cash Flows from Financing Activities
|
|
|
|
||||
|
Borrowings under line of credit
|
55,500
|
|
|
48,000
|
|
||
|
Repayments under line of credit
|
(67,500
|
)
|
|
(55,000
|
)
|
||
|
Repayments of long-term debt and capital leases
|
(931
|
)
|
|
(2,861
|
)
|
||
|
Exercise of stock options
|
26
|
|
|
—
|
|
||
|
Excess tax benefits from stock-based payment arrangements
|
295
|
|
|
—
|
|
||
|
Net cash used in financing activities
|
(12,610
|
)
|
|
(9,861
|
)
|
||
|
Decrease in cash and cash equivalents
|
(3,252
|
)
|
|
(1,421
|
)
|
||
|
Cash and cash equivalents at beginning of period
|
4,192
|
|
|
3,528
|
|
||
|
Cash and cash equivalents at end of period
|
$
|
940
|
|
|
$
|
2,107
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2011
|
|
2010
|
||||
|
Supplemental cash flow information
|
|
|
|
||||
|
Cash paid for:
|
|
|
|
||||
|
Interest expense, net of capitalized interest
|
$
|
12,578
|
|
|
$
|
9,802
|
|
|
Income taxes (refund) paid, net
|
$
|
(122
|
)
|
|
$
|
15
|
|
|
Non-cash activities:
|
|
|
|
||||
|
Conversion of accounts receivable into notes receivable, net
|
$
|
1,529
|
|
|
$
|
—
|
|
|
Insurance premium financed
|
$
|
945
|
|
|
$
|
1,100
|
|
|
|
Three Months Ended
March 31, 2011 |
|
Three Months Ended
March 31, 2010 |
||||||||||||||||||||
|
|
Class A
|
|
Class B
|
|
Total
|
|
Class A
|
|
Class B
|
|
Total
|
||||||||||||
|
Earnings per share, basic
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Numerator:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Allocation of net income
|
$
|
6,416
|
|
|
$
|
5,428
|
|
|
$
|
11,844
|
|
|
$
|
4,796
|
|
|
$
|
4,085
|
|
|
$
|
8,881
|
|
|
Earnings per share, diluted
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Numerator:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Allocation of net income
|
$
|
6,452
|
|
|
$
|
5,392
|
|
|
$
|
11,844
|
|
|
$
|
4,804
|
|
|
$
|
4,077
|
|
|
$
|
8,881
|
|
|
Denominator for basic and diluted earnings per share:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Weighted average common shares outstanding, basic
|
20,086
|
|
|
16,993
|
|
|
37,079
|
|
|
19,961
|
|
|
17,001
|
|
|
36,962
|
|
||||||
|
Plus: incremental shares related to dilutive effect of stock options and restricted stock, if applicable
|
247
|
|
|
—
|
|
|
247
|
|
|
75
|
|
|
—
|
|
|
75
|
|
||||||
|
Adjusted weighted-average common shares outstanding, diluted
|
20,333
|
|
|
16,993
|
|
|
37,326
|
|
|
20,036
|
|
|
17,001
|
|
|
37,037
|
|
||||||
|
Earnings per share, basic:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Earnings per share
|
$
|
0.32
|
|
|
$
|
0.32
|
|
|
$
|
0.32
|
|
|
$
|
0.24
|
|
|
$
|
0.24
|
|
|
$
|
0.24
|
|
|
Earnings per share, diluted:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Earnings per share
|
$
|
0.32
|
|
|
$
|
0.32
|
|
|
$
|
0.32
|
|
|
$
|
0.24
|
|
|
$
|
0.24
|
|
|
$
|
0.24
|
|
|
|
Three Months Ended
March 31, |
||||
|
|
2011
|
|
2010
|
||
|
Options to purchase common shares
|
38
|
|
|
793
|
|
|
Non-vested common shares
|
261
|
|
|
7
|
|
|
Total excluded
|
299
|
|
|
800
|
|
|
|
Long-term
Care Services
|
|
Therapy Services
|
|
Hospice & Home Health Services
|
|
Other
|
|
Elimination
|
|
Total
|
||||||||||||
|
Three Months Ended March 31, 2011
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Revenue from external customers
|
$
|
182,323
|
|
|
$
|
22,190
|
|
|
$
|
18,065
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
222,578
|
|
|
Intersegment revenue
|
390
|
|
|
17,121
|
|
|
—
|
|
|
—
|
|
|
(17,511
|
)
|
|
—
|
|
||||||
|
Total revenue
|
$
|
182,713
|
|
|
$
|
39,311
|
|
|
$
|
18,065
|
|
|
$
|
—
|
|
|
$
|
(17,511
|
)
|
|
$
|
222,578
|
|
|
Operating income (loss)
|
$
|
27,276
|
|
|
$
|
5,959
|
|
|
$
|
3,333
|
|
|
$
|
(7,059
|
)
|
|
$
|
—
|
|
|
$
|
29,509
|
|
|
Interest expense, net of interest income
|
|
|
|
|
|
|
|
|
|
|
(9,771
|
)
|
|||||||||||
|
Other income
|
|
|
|
|
|
|
|
|
|
|
(324
|
)
|
|||||||||||
|
Equity in earnings of joint venture
|
|
|
|
|
|
|
|
|
|
|
554
|
|
|||||||||||
|
Income before provision for income taxes
|
|
|
|
|
|
|
|
|
|
|
$
|
19,968
|
|
||||||||||
|
Depreciation and amortization
|
$
|
5,692
|
|
|
$
|
98
|
|
|
$
|
204
|
|
|
$
|
151
|
|
|
$
|
—
|
|
|
$
|
6,145
|
|
|
Segment capital expenditures
|
$
|
2,247
|
|
|
$
|
51
|
|
|
$
|
155
|
|
|
$
|
114
|
|
|
$
|
—
|
|
|
$
|
2,567
|
|
|
Adjusted EBITDA
|
$
|
33,318
|
|
|
$
|
6,057
|
|
|
$
|
3,583
|
|
|
$
|
(6,157
|
)
|
|
$
|
—
|
|
|
$
|
36,801
|
|
|
Adjusted EBITDAR
|
$
|
37,635
|
|
|
$
|
6,060
|
|
|
$
|
3,819
|
|
|
$
|
(6,143
|
)
|
|
$
|
—
|
|
|
$
|
41,371
|
|
|
Three Months Ended March 31, 2010
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Revenue from external customers
|
$
|
169,226
|
|
|
$
|
17,007
|
|
|
3,086
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
189,319
|
|
|
|
Intersegment revenue
|
363
|
|
|
16,785
|
|
|
—
|
|
|
—
|
|
|
(17,148
|
)
|
|
—
|
|
||||||
|
Total revenue
|
$
|
169,589
|
|
|
$
|
33,792
|
|
|
3,086
|
|
|
$
|
—
|
|
|
$
|
(17,148
|
)
|
|
$
|
189,319
|
|
|
|
Operating income (loss)
|
$
|
22,292
|
|
|
$
|
5,115
|
|
|
(22
|
)
|
|
$
|
(6,647
|
)
|
|
$
|
—
|
|
|
$
|
20,738
|
|
|
|
Interest expense, net of interest income
|
|
|
|
|
|
|
|
|
|
|
(7,056
|
)
|
|||||||||||
|
Other expense
|
|
|
|
|
|
|
|
|
|
|
(4
|
)
|
|||||||||||
|
Equity in earnings of joint venture
|
|
|
|
|
|
|
|
|
|
|
797
|
|
|||||||||||
|
Income before provision for income taxes
|
|
|
|
|
|
|
|
|
|
|
$
|
14,475
|
|
||||||||||
|
Depreciation and amortization
|
$
|
5,519
|
|
|
$
|
79
|
|
|
$
|
70
|
|
|
$
|
276
|
|
|
$
|
—
|
|
|
$
|
5,944
|
|
|
Segment capital expenditures
|
$
|
9,661
|
|
|
$
|
32
|
|
|
$
|
—
|
|
|
$
|
5
|
|
|
$
|
—
|
|
|
$
|
9,698
|
|
|
Adjusted EBITDA
|
$
|
27,811
|
|
|
$
|
5,194
|
|
|
$
|
208
|
|
|
$
|
(5,738
|
)
|
|
$
|
—
|
|
|
$
|
27,475
|
|
|
Adjusted EBITDAR
|
$
|
32,252
|
|
|
$
|
5,262
|
|
|
$
|
259
|
|
|
$
|
(5,717
|
)
|
|
$
|
—
|
|
|
$
|
32,056
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2011
|
|
2010
|
||||
|
Adjusted EBITDAR
|
$
|
41,371
|
|
|
$
|
32,056
|
|
|
Rent cost of revenue
|
(4,570
|
)
|
|
(4,581
|
)
|
||
|
Adjusted EBITDA
|
36,801
|
|
|
27,475
|
|
||
|
Depreciation and amortization
|
(6,145
|
)
|
|
(5,944
|
)
|
||
|
Interest expense
|
(9,946
|
)
|
|
(7,284
|
)
|
||
|
Interest income
|
175
|
|
|
228
|
|
||
|
Disposal of property and equipment
|
(290
|
)
|
|
—
|
|
||
|
Transaction cost
|
(242
|
)
|
|
—
|
|
||
|
Exit costs related to Northern California divestiture
|
(385
|
)
|
|
—
|
|
||
|
Provision for income taxes
|
(8,124
|
)
|
|
(5,594
|
)
|
||
|
Net income
|
$
|
11,844
|
|
|
$
|
8,881
|
|
|
|
Long-term
Care Services
|
|
Therapy Services
|
|
Hospice & Home Health Services
|
|
Other
|
|
Total
|
|||||||||
|
March 31, 2011:
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Segment total assets
|
$
|
714,403
|
|
|
$
|
84,695
|
|
|
78,627
|
|
|
$
|
63,386
|
|
|
$
|
941,111
|
|
|
Goodwill and intangibles included in total assets
|
$
|
244,515
|
|
|
$
|
50,993
|
|
|
62,662
|
|
|
$
|
—
|
|
|
$
|
358,170
|
|
|
December 31, 2010:
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Segment total assets
|
$
|
717,668
|
|
|
$
|
81,863
|
|
|
76,950
|
|
|
$
|
67,809
|
|
|
$
|
944,290
|
|
|
Goodwill and intangibles included in total assets
|
$
|
244,760
|
|
|
$
|
50,993
|
|
|
62,312
|
|
|
$
|
—
|
|
|
$
|
358,065
|
|
|
|
March 31, 2011
|
|
December 31, 2010
|
||||
|
Current portion of notes receivable, net
|
$
|
3,827
|
|
|
$
|
3,824
|
|
|
Supplies inventory
|
2,809
|
|
|
2,809
|
|
||
|
Income tax refund receivable
|
10,783
|
|
|
9,074
|
|
||
|
Other current assets
|
103
|
|
|
112
|
|
||
|
|
$
|
17,522
|
|
|
$
|
15,819
|
|
|
|
March 31, 2011
|
|
December 31, 2010
|
||||
|
Equity investment in joint ventures
|
$
|
5,391
|
|
|
$
|
5,379
|
|
|
Restricted cash
|
15,181
|
|
|
14,502
|
|
||
|
Deposits and other assets
|
12,501
|
|
|
11,155
|
|
||
|
|
$
|
33,073
|
|
|
$
|
31,036
|
|
|
|
March 31, 2011
|
|
December 31, 2010
|
||||
|
Deferred rent
|
$
|
6,433
|
|
|
$
|
6,148
|
|
|
Other long-term tax liability
|
18
|
|
|
18
|
|
||
|
Asbestos abatement liability
|
3,908
|
|
|
3,871
|
|
||
|
Other noncurrent liabilities
|
6,564
|
|
|
5,947
|
|
||
|
|
$
|
16,923
|
|
|
$
|
15,984
|
|
|
|
As of March 31, 2011
|
|
As of December 31, 2010
|
||||||||||||||||||||||||||||
|
|
General and
Professional
|
|
Employee
Medical
|
|
Workers’
Compensation
|
|
Total
|
|
General and
Professional
|
|
Employee
Medical
|
|
Workers’
Compensation
|
|
Total
|
||||||||||||||||
|
Current
|
$
|
4,241
|
|
(1)
|
$
|
2,534
|
|
(2)
|
$
|
4,484
|
|
(2)
|
$
|
11,259
|
|
|
$
|
4,037
|
|
(1)
|
$
|
1,965
|
|
(2)
|
$
|
4,484
|
|
(2)
|
$
|
10,486
|
|
|
Non-current
|
21,184
|
|
|
—
|
|
|
12,362
|
|
|
33,546
|
|
|
20,124
|
|
|
—
|
|
|
11,910
|
|
|
32,034
|
|
||||||||
|
|
$
|
25,425
|
|
|
$
|
2,534
|
|
|
$
|
16,846
|
|
|
$
|
44,805
|
|
|
$
|
24,161
|
|
|
$
|
1,965
|
|
|
$
|
16,394
|
|
|
$
|
42,520
|
|
|
(1)
|
Included in accounts payable and accrued liabilities.
|
|
(2)
|
Included in employee compensation and benefits.
|
|
|
Three Months Ended March 31,
|
||||||
|
|
2011
|
|
2010
|
||||
|
Risk-free interest rate
|
2.80
|
%
|
|
2.71
|
%
|
||
|
Expected Life
|
6.25 years
|
|
|
6.25 years
|
|
||
|
Dividend yield
|
—
|
%
|
|
—
|
%
|
||
|
Volatility
|
50.00
|
%
|
|
45.00
|
%
|
||
|
Weighted-average fair value
|
$
|
6.61
|
|
|
$
|
2.80
|
|
|
|
Number of
Shares
|
|
Weighted-
Average
Exercise
Price
|
|
Weighted-
Average
Remaining
Contractual
Term
(in years)
|
|
Aggregate
Intrinsic
Value
(in thousands)
|
||||||
|
Outstanding at January 1, 2011
|
998,578
|
|
|
$
|
9.01
|
|
|
|
|
|
|||
|
Granted
|
60,491
|
|
|
$
|
12.87
|
|
|
|
|
|
|||
|
Exercised
|
(2,770
|
)
|
|
$
|
10.04
|
|
|
|
|
|
|||
|
Forfeited or cancelled
|
(7,500
|
)
|
|
$
|
15.78
|
|
|
|
|
|
|||
|
Outstanding at March 31, 2011
|
1,048,799
|
|
|
$
|
9.19
|
|
|
8.17
|
|
|
$
|
5,592
|
|
|
Fully vested and expected to vest at March 31, 2011
|
1,008,708
|
|
|
$
|
9.25
|
|
|
8.14
|
|
|
$
|
5,324
|
|
|
Exercisable at March 31, 2011
|
426,268
|
|
|
$
|
11.10
|
|
|
7.40
|
|
|
$
|
1,531
|
|
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||
|
Interest rate hedges
|
$
|
—
|
|
|
$
|
(298
|
)
|
|
$
|
—
|
|
|
$
|
(298
|
)
|
|
Contingent Consideration – acquisition
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
5,442
|
|
|
$
|
5,442
|
|
|
Level 3 Rollforward
|
|
||
|
Value at January 1, 2011
|
$
|
5,350
|
|
|
Change in fair value
|
92
|
|
|
|
Value at March 31, 2011
|
5,442
|
|
|
|
|
As of
March 31, 2011
|
|
As of
December 31, 2010
|
||||
|
Revolving Credit Facility, interest rate comprised of LIBOR (subject to a 1.50% floor) plus 3.75% or 5.25%; collateralized by substantially all assets of the Company; amount due 2015
|
$
|
14,000
|
|
|
$
|
26,000
|
|
|
Term Loan, interest rate based on LIBOR (subject to a 1.50% floor) plus 3.75%, or 5.25%; net original issue discount of $2,253 and $2,365 at March 31, 2011 and December 31, 2010, respectively; collateralized by substantially all assets of the Company; amount due 2016
|
354,147
|
|
|
354,935
|
|
||
|
2014 Senior Subordinated Notes, interest rate 11.0%, with an original issue discount of $304 and $331 at March 31, 2011 and December 31, 2010, respectively, interest payable semiannually, principal due 2014
|
129,696
|
|
|
129,669
|
|
||
|
Notes payable, interest rate fixed at 6.5%, payable in monthly installments, collateralized by a first priority deed of trust, due December 2018
|
1,376
|
|
|
1,411
|
|
||
|
Hospice/Home Health Acquisition note, interest rate fixed at 6.00%, payable in annual installments
|
7,955
|
|
|
7,948
|
|
||
|
Insurance premiums financed
|
945
|
|
|
—
|
|
||
|
Total long-term debt and capital leases
|
508,119
|
|
|
519,963
|
|
||
|
Less amounts due within one year
|
(6,689
|
)
|
|
(5,742
|
)
|
||
|
Long-term debt and capital leases, net of current portion
|
$
|
501,430
|
|
|
$
|
514,221
|
|
|
|
Three Months Ended March 31,
|
|
|
|||||||||||||||||
|
|
2011
|
|
2010
|
|
|
|||||||||||||||
|
|
Revenue
Dollars
|
|
Revenue
Percentage
|
|
Revenue
Dollars
|
|
Revenue
Percentage
|
|
Increase/(Decrease)
|
|||||||||||
|
Dollars
|
|
Percentage
|
||||||||||||||||||
|
Long-term care services:
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Skilled nursing facilities
|
$
|
175,344
|
|
|
78.8
|
%
|
|
$
|
162,874
|
|
|
86.0
|
%
|
|
$
|
12,470
|
|
|
7.7
|
%
|
|
Assisted living facilities
|
6,724
|
|
|
3.0
|
|
|
6,147
|
|
|
3.2
|
|
|
577
|
|
|
9.4
|
|
|||
|
Administration of third party facilities
|
255
|
|
|
0.1
|
|
|
205
|
|
|
0.1
|
|
|
50
|
|
|
24.4
|
|
|||
|
Total long-term care services
|
182,323
|
|
|
81.9
|
|
|
169,226
|
|
|
89.3
|
|
|
13,097
|
|
|
7.7
|
|
|||
|
Therapy services:
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Third-party rehabilitation therapy services
|
22,190
|
|
|
10.0
|
|
|
17,007
|
|
|
9.1
|
|
|
5,183
|
|
|
30.5
|
|
|||
|
Total therapy services
|
22,190
|
|
|
10.0
|
|
|
17,007
|
|
|
9.1
|
|
|
5,183
|
|
|
30.5
|
|
|||
|
Hospice & Home Health services:
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Hospice
|
14,326
|
|
|
6.4
|
|
|
3,086
|
|
|
1.6
|
|
|
11,240
|
|
|
364.0
|
|
|||
|
Home Health
|
3,739
|
|
|
1.7
|
|
|
—
|
|
|
—
|
|
|
3,739
|
|
|
100.0
|
|
|||
|
Total hospice & home health services
|
18,065
|
|
|
8.1
|
|
|
3,086
|
|
|
1.6
|
|
|
14,979
|
|
|
485.0
|
|
|||
|
Total
|
$
|
222,578
|
|
|
100.0
|
%
|
|
$
|
189,319
|
|
|
100.0
|
%
|
|
$
|
33,259
|
|
|
17.6
|
%
|
|
|
Three Months Ended March 31,
|
||||||||||||
|
|
2011
|
|
2010
|
||||||||||
|
|
Revenue Dollars
|
|
Percentage of
Revenue
|
|
Revenue Dollars
|
|
Percentage of
Revenue
|
||||||
|
California
|
$
|
94,953
|
|
|
42.7
|
%
|
|
$
|
82,345
|
|
|
43.5
|
%
|
|
Texas
|
46,348
|
|
|
20.8
|
|
|
46,947
|
|
|
24.8
|
|
||
|
New Mexico
|
22,171
|
|
|
10.0
|
|
|
20,868
|
|
|
11.0
|
|
||
|
Kansas
|
17,857
|
|
|
8.0
|
|
|
14,767
|
|
|
7.8
|
|
||
|
Missouri
|
15,319
|
|
|
6.9
|
|
|
14,637
|
|
|
7.7
|
|
||
|
Nevada
|
14,719
|
|
|
6.6
|
|
|
7,739
|
|
|
4.1
|
|
||
|
Montana
|
2,875
|
|
|
1.3
|
|
|
—
|
|
|
—
|
|
||
|
Iowa
|
2,971
|
|
|
1.3
|
|
|
2,002
|
|
|
1.1
|
|
||
|
Arizona
|
2,893
|
|
|
1.3
|
|
|
—
|
|
|
—
|
|
||
|
Idaho
|
2,191
|
|
|
1.0
|
|
|
—
|
|
|
—
|
|
||
|
Other
|
281
|
|
|
0.1
|
|
|
14
|
|
|
—
|
|
||
|
Total
|
$
|
222,578
|
|
|
100.0
|
%
|
|
$
|
189,319
|
|
|
100.0
|
%
|
|
|
Three Months Ended
March 31, |
||||
|
|
2011
|
|
2010
|
||
|
Medicare
|
16.4
|
%
|
|
16.1
|
%
|
|
Managed care
|
8.1
|
|
|
6.9
|
|
|
Skilled mix
|
24.5
|
|
|
23.0
|
|
|
Private pay and other
|
15.4
|
|
|
16.5
|
|
|
Medicaid
|
60.1
|
|
|
60.5
|
|
|
Total
|
100.0
|
%
|
|
100.0
|
%
|
|
|
Three Months Ended March 31,
|
||||||||||||
|
|
2011
|
|
2010
|
||||||||||
|
|
Revenue
Dollars
|
|
Revenue
Percentage
|
|
Revenue
Dollars
|
|
Revenue
Percentage
|
||||||
|
Medicare
|
$
|
88,217
|
|
|
39.6
|
%
|
|
$
|
65,694
|
|
|
34.8
|
%
|
|
Medicaid
|
64,031
|
|
|
28.8
|
|
|
62,725
|
|
|
33.1
|
|
||
|
Subtotal Medicare and Medicaid
|
152,248
|
|
|
68.4
|
|
|
128,419
|
|
|
67.9
|
|
||
|
Managed Care
|
22,194
|
|
|
10.0
|
|
|
18,237
|
|
|
9.6
|
|
||
|
Private pay and other
|
48,136
|
|
|
21.6
|
|
|
42,663
|
|
|
22.5
|
|
||
|
Total
|
$
|
222,578
|
|
|
100.0
|
%
|
|
$
|
189,319
|
|
|
100.0
|
%
|
|
•
|
Enhanced CMPs and Escrow Provisions.
Effective March 23, 2010, PPACA includes expanded civil monetary penalty (“CMP”) provisions applicable to all Medicare and Medicaid providers. Sections 6402 and 6408 of PPACA provide for the imposition of CMPs of up to $50,000 and, in some cases, treble damages, for actions relating to alleged false statements to the federal government. Section 6111 of PPACA also includes CMP provisions specific to skilled nursing facilities that in limited circumstances provide for up to a fifty percent (50%) reduction in CMPs where a facility self-reports and promptly corrects an alleged deficiency within ten (10) calendar days. In addition, the new CMP provisions specific to skilled nursing facilities provide that the Secretary of Health and Human Services may provide for the collection and placement of the CMP amount into an escrow account on the earlier of the date informal dispute resolution is completed or ninety (90) days after the imposition of the CMP. If an appeal is successful, the facility would receive a refund of the collected amounts with interest. This CMP escrow provision is a departure from prior policy, which only required remittance of CMP amounts following the final disposition of a CMP dispute. On March 18, 2011, CMS published a final rule implementing Section 6111 of PPACA. Among other things, the final rule implements the changes listed above regarding CMS's new authority to reduce CMPs by up to 50% in limited circumstances and CMS's ability to place CMPs into an escrow account pending a final administrative decision addressing the alleged violation. The final rule also allows CMS to defer full payment of CMP into an escrow account if it determines that more time is necessary for the deposit of the total amount by finding that immediate payment would create substantial and undue hardship on the facility. To the extent our facilities are assessed large CMPs that are collected and placed into an escrow account pending lengthy appeals, such actions could adversely affect the results of operations.
|
|
•
|
Nursing Home Transparency Requirements.
In addition to expanded CMP provisions, PPACA imposes substantial new transparency requirements for Medicare-participating nursing facilities. Existing law requires Medicare providers to disclose to CMS: (1) any person or entity that owns directly or indirectly an ownership interest of five percent (5%) or more in a provider; (2) officers and directors (if a corporation) and partners (if a partnership); and (3) holders of a mortgage, deed of trust, note or other obligation secured by the entity or the property of the entity. Section 6101 of the PPACA expands the information required to be disclosed to include: (4) the facility’s organizational structure; (5) additional information on officers, directors, trustees, and “managing employees” of the facility (including their names, titles, and start dates of services); and (6) information on any “additional disclosable party” of the facility. “Managing employee” is defined broadly as an individual (including a general manager, business manager, administrator, director, or consultant) who directly or indirectly manages, advises, or supervises any element of the practices, finances, or operations of the facility. “Additional disclosable party” of the facility is defined as any person or entity that (1) exercises operational, financial, or managerial control over the facility, or provides policies or procedures for the operations of the facility, or provides financial or cash management services to the facility; (2) leases or subleases real property to the facility, or owns a whole or partial interest equal to or exceeding five
|
|
•
|
Face-to-face encounter requirements
. PPACA also imposes on home health agencies and hospices new face-to-face encounter requirements with patients. Effective April 1, 2011, CMS expects home health agencies to have fully established internal processes to comply with the face-to-face encounter requirements mandated by PPACA for purposes of certification of a patient's eligibility for Medicare home health services. Under the requirements set forth in Section 6407 of PPACA, the certifying physician must document that he or she, or a non-physician practitioner working with the physician, has seen the patient. The encounter must occur within the 90 days prior to the start of care, or within the 30 days after the start of care. Documentation of such an encounter must be present on certifications for patients with starts of care on or after January 1, 2011. Also effective April 1, 2011, hospices are required to have processes to comply with face-to-face encounter requirements under PPACA for purposes of recertification for Medicare hospice services. Under Section 3132(b) of PPACA, a hospice physician or nurse practitioner is required to have a face-to-face encounter with a hospice patient prior to the patient's 180th-day recertification, and each subsequent recertification. The encounter must occur no more than 30 calendar days prior to the start of the hospice patient's third benefit period. The provision applies to recertifications on and after January 1, 2011.
|
|
•
|
Suspension of Payments During Pending Fraud Investigations.
PPACA also provides the federal government with expanded authority to suspend payment if a provider is investigated for allegations or issues of fraud. Section 6402 of PPACA provides that, beginning March 23, 2010, Medicare and Medicaid payments may be suspended pending a “credible investigation of fraud,” unless the Secretary of Health and Human Services determines that good cause exists not to suspend payments. “Credible investigation of fraud” is undefined, although the Secretary must consult with the Office of the Inspector General in determining whether a credible investigation of fraud exists. This suspension authority creates a new mechanism for the federal government to suspend both Medicare and Medicaid payments for allegations of fraud, independent of whether a state exercises its authority to suspend Medicaid payments pending a fraud investigation. To the extent the Secretary applies this suspension of payments provision to one of our facilities for allegations of fraud, such a suspension could adversely affect the results of operations.
|
|
•
|
Overpayment Reporting and Repayment; Expanded False Claims Act Liability.
The PPACA also enacted several important changes that expand potential liability under the federal False Claims Act. Effective March 23, 2010, Section 6402 of the PPACA provides that overpayments related to services provided to both Medicare and Medicaid beneficiaries must be reported and returned to the applicable payor within the later of sixty (60) days of identification of the overpayment, or the date the corresponding cost report (if applicable) is due. Any overpayment retained after the deadline is considered an “obligation” for purposes of the federal False Claims Act. This new provision substantially tightens the repayment and reporting requirements generally associated with operations of health care providers to avoid FCA exposure. To the extent we incur additional operational costs to comply with the new overpayment reporting and repayment provision, such costs may adversely affect the results of operations.
|
|
•
|
Community First Choice Option
. Section 2401 of PPACA establishes a new State option, available starting October 1, 2011, under which states can provide home and community-based attendant services and supports through the Community First Choice State plan option. States choosing to provide home and community based services under this option shall make them available to assist with activities of daily living, instrumental activities of daily living and health related tasks under a plan of care agreed upon by the individual and his/her representative. PPACA specifies the models of delivery through which such services may be available and enumerates the types of services that may be covered. For states that elect to make coverage of home and community based services available through the Community First Choice State plan option, FMAP is increased by six percentage points, and thus this Section incentivizes states to expand their home and community based services. On February 25, 2011, CMS published a proposed rule implementing Section 2401 of PPACA. Comments on the proposed rule were due by April 26, 2011. The expansion of home and community based services has the potential to reduce the demand for the long-term care and nursing services that we provide.
|
|
•
|
Health Care-Acquired Conditions
.
PPACA also provides that the Secretary of Health and Human Services shall prohibit payments to States for any amounts expended for providing medical assistance for health care-acquired conditions. A health care-acquired condition is defined as a medical condition for which an individual was diagnosed that could be identified by a secondary diagnostic code described in the Social Security Act as follows: (i) cases
|
|
•
|
Removal of Barriers to Providing Home and Community Based Services
.
Also effective January 1, 2011, Section 2402 of PPACA includes additional measures related to the expansion of community and home based services. It requires the Secretary to adopt regulations that will ensure that states will develop systems that allow beneficiaries to obtain, as well as maintain, non-institutional services, and have a say in the design of their treatment. This Section also authorizes states to expand coverage of community and home based services to individuals who would not otherwise be eligible for them.
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2011
|
|
2010
|
||||
|
Occupancy statistics (skilled nursing facilities):
|
|
|
|
||||
|
Available beds in service at end of period
|
9,179
|
|
|
9,242
|
|
||
|
Available patient days
|
824,753
|
|
|
832,518
|
|
||
|
Actual patient days
|
690,808
|
|
|
697,541
|
|
||
|
Occupancy percentage
|
83.8
|
%
|
|
83.8
|
%
|
||
|
Average daily number of patients
|
7,676
|
|
|
7,751
|
|
||
|
Revenue per patient day (skilled nursing facilities prior to intercompany eliminations)
|
|
|
|
||||
|
LTC only Medicare (Part A)
|
$
|
577
|
|
|
$
|
497
|
|
|
Medicare blended rate (Part A & B)
|
630
|
|
|
557
|
|
||
|
Managed care
|
391
|
|
|
380
|
|
||
|
Medicaid
|
153
|
|
|
149
|
|
||
|
Private and other
|
175
|
|
|
170
|
|
||
|
Weighted-average for all
|
$
|
254
|
|
|
$
|
234
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2011
|
|
2010
|
||||
|
Revenue
|
100.0
|
%
|
|
100.0
|
%
|
||
|
Expenses:
|
|
|
|
||||
|
Cost of services (exclusive of rent cost of revenue and depreciation and amortization shown below)
|
78.8
|
|
|
80.1
|
|
||
|
Rent cost of revenue
|
2.1
|
|
|
2.4
|
|
||
|
General and administrative
|
3.1
|
|
|
3.4
|
|
||
|
Depreciation and amortization
|
2.8
|
|
|
3.1
|
|
||
|
|
86.8
|
|
|
89.0
|
|
||
|
Other income (expenses):
|
|
|
|
||||
|
Interest expense
|
(4.5
|
)
|
|
(3.8
|
)
|
||
|
Interest income
|
0.1
|
|
|
0.1
|
|
||
|
Other income (expense)
|
(0.1
|
)
|
|
—
|
|
||
|
Equity in earnings of joint venture
|
0.2
|
|
|
0.4
|
|
||
|
Total other expenses, net
|
(4.3
|
)
|
|
(3.3
|
)
|
||
|
Income from continuing operations before provision for income taxes
|
8.9
|
|
|
7.7
|
|
||
|
Provision for income taxes
|
3.6
|
|
|
3.0
|
|
||
|
Net income
|
5.3
|
|
|
4.7
|
|
||
|
|
|
|
|
||||
|
|
|
|
|
||||
|
EBITDA(1)
|
16.1
|
%
|
|
14.5
|
%
|
||
|
Adjusted EBITDA(1)
|
16.5
|
%
|
|
14.5
|
%
|
||
|
EBITDAR (2)
|
18.2
|
%
|
|
16.9
|
%
|
||
|
Adjusted EBITDAR(2)
|
18.6
|
%
|
|
16.9
|
%
|
||
|
|
Three Months Ended
March 31, |
||||||
|
|
2011
|
|
2010
|
||||
|
Reconciliation from net income to EBITDA, EBITDAR, Adjusted EBITDA and Adjusted EBITDAR (in thousands):
|
|
|
|
||||
|
Net Income
|
$
|
11,844
|
|
|
$
|
8,881
|
|
|
Interest expense, net of interest income
|
9,771
|
|
|
7,056
|
|
||
|
Provision for income taxes
|
8,124
|
|
|
5,594
|
|
||
|
Depreciation and amortization expense
|
6,145
|
|
|
5,944
|
|
||
|
EBITDA
|
35,884
|
|
|
27,475
|
|
||
|
Rent cost of revenue
|
4,570
|
|
|
4,581
|
|
||
|
EBITDAR
|
40,454
|
|
|
32,056
|
|
||
|
EBITDA
|
35,884
|
|
|
27,475
|
|
||
|
Disposal of property and equipment
|
290
|
|
|
—
|
|
||
|
Transaction cost
|
242
|
|
|
—
|
|
||
|
Exit costs related to Northern California divestiture
|
385
|
|
|
—
|
|
||
|
Adjusted EBITDA
|
36,801
|
|
|
27,475
|
|
||
|
Rent cost of revenue
|
4,570
|
|
|
4,581
|
|
||
|
Adjusted EBITDAR
|
$
|
41,371
|
|
|
$
|
32,056
|
|
|
(1)
|
We define EBITDA as net income (loss) before depreciation, amortization and interest expense (net of interest income) and the provision for (benefit from) income taxes. EBITDA margin is EBITDA as a percentage of revenue. Adjusted EBITDA is EBITDA adjusted for non-core business items, which for this report includes gains or losses on sale of assets, due diligence, and exit cost (each to the extent applicable in the appropriate period.)
|
|
(2)
|
We define EBITDAR as net income (loss) before depreciation, amortization, interest expense (net of interest income), the provision for (benefit from) income taxes and rent cost of revenue. EBITDAR margin is EBITDAR as a percentage of revenue. Adjusted EBITDAR is EBITDAR adjusted for the Adjusted EBITDA items listed above (each to the extent applicable in the appropriate period.)
|
|
•
|
they do not reflect our cash expenditures, or future requirements, for capital expenditures or contractual commitments;
|
|
•
|
they do not reflect changes in, or cash requirements for, our working capital needs;
|
|
•
|
they do not reflect the interest expense, or the cash requirements necessary to service interest or principal payments, on our debt;
|
|
•
|
they do not reflect any income tax payments we may be required to make;
|
|
•
|
although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and EBITDA and Adjusted EBITDA do not reflect any cash requirements for such replacements;
|
|
•
|
they are not adjusted for all non-cash income or expense items that are reflected in our consolidated statements of cash flows;
|
|
•
|
they do not reflect the impact on earnings of charges resulting from certain matters we consider not to be indicative of our ongoing operations; and
|
|
•
|
other companies in our industry may calculate these measures differently than we do, which may limit their usefulness as comparative measures.
|
|
|
Three Months Ended March 31,
|
|
|
|||||||||||||||||
|
|
2011
|
|
2010
|
|
Increase/(Decrease)
|
|||||||||||||||
|
|
Revenue
Dollars
|
|
Revenue
Percentage
|
|
Revenue
Dollars
|
|
Revenue
Percentage
|
|
Dollars
|
|
Percentage
|
|||||||||
|
|
(dollars in millions)
|
|||||||||||||||||||
|
Skilled nursing facilities
|
$
|
175.3
|
|
|
78.8
|
%
|
|
$
|
162.9
|
|
|
86.1
|
%
|
|
$
|
12.4
|
|
|
7.6
|
%
|
|
Assisted living facilities
|
6.7
|
|
|
3.0
|
|
|
6.1
|
|
|
3.2
|
|
|
0.6
|
|
|
9.8
|
|
|||
|
Administration of third party facilities
|
0.3
|
|
|
0.1
|
|
|
0.2
|
|
|
0.1
|
|
|
0.1
|
|
|
50.0
|
|
|||
|
Total long-term care services
|
$
|
182.3
|
|
|
81.9
|
%
|
|
$
|
169.2
|
|
|
89.4
|
%
|
|
$
|
13.1
|
|
|
7.7
|
%
|
|
|
Three Months Ended March 31,
|
|
|
|||||||||||||||||
|
|
2011
|
|
2010
|
|
Increase/(Decrease)
|
|||||||||||||||
|
|
Revenue
Dollars
|
|
Revenue
Percentage
|
|
Revenue
Dollars
|
|
Revenue
Percentage
|
|
Dollars
|
|
Percentage
|
|||||||||
|
|
(dollars in millions)
|
|||||||||||||||||||
|
Rehabilitation therapy services
|
$
|
39.3
|
|
|
17.7
|
%
|
|
$
|
33.8
|
|
|
17.9
|
%
|
|
$
|
5.5
|
|
|
16.3
|
%
|
|
Intersegment elimination services related to affiliated entities
|
(17.1
|
)
|
|
(7.7
|
)
|
|
(16.8
|
)
|
|
(8.9
|
)
|
|
(0.3
|
)
|
|
(1.8
|
)
|
|||
|
Total therapy services
|
$
|
22.2
|
|
|
10.0
|
%
|
|
$
|
17.0
|
|
|
9.0
|
%
|
|
$
|
5.2
|
|
|
30.6
|
%
|
|
|
Three Months Ended March 31,
|
|
|
|||||||||||||||||
|
|
2011
|
|
2010
|
|
Increase/(Decrease)
|
|||||||||||||||
|
|
Revenue
Dollars
|
|
Revenue
Percentage
|
|
Revenue
Dollars
|
|
Revenue
Percentage
|
|
Dollars
|
|
Percentage
|
|||||||||
|
|
(dollars in millions)
|
|||||||||||||||||||
|
Hospice
|
$
|
14.3
|
|
|
6.4
|
%
|
|
$
|
3.1
|
|
|
1.6
|
%
|
|
$
|
11.2
|
|
|
361.3
|
%
|
|
Home Health
|
3.7
|
|
|
1.7
|
|
|
—
|
|
|
—
|
|
|
3.7
|
|
|
100.0
|
|
|||
|
Total hospice & home health services
|
$
|
18.0
|
|
|
8.1
|
%
|
|
$
|
3.1
|
|
|
1.6
|
%
|
|
$
|
14.9
|
|
|
480.6
|
%
|
|
|
Three Months Ended March 31,
|
|
|
|||||||||||||||||
|
|
2011
|
|
2010
|
|
Increase/(Decrease)
|
|||||||||||||||
|
|
Cost of Service
Dollars
(prior to
intersegment
eliminations)
|
|
Revenue
Percentage
|
|
Cost of Service
Dollars
(prior to
intersegment
eliminations)
|
|
Revenue
Percentage
|
|
||||||||||||
|
|
||||||||||||||||||||
|
|
Dollars
|
|
Percentage
|
|||||||||||||||||
|
|
(dollars in millions)
|
|||||||||||||||||||
|
Skilled nursing facilities
|
$
|
134.3
|
|
|
76.6
|
%
|
|
$
|
127.3
|
|
|
78.1
|
%
|
|
$
|
7.0
|
|
|
5.5
|
%
|
|
Assisted living facilities
|
4.8
|
|
|
71.6
|
|
|
4.3
|
|
|
70.5
|
|
|
0.5
|
|
|
11.6
|
|
|||
|
Regional operations support
|
6.3
|
|
|
n/a
|
|
|
5.6
|
|
|
n/a
|
|
|
0.7
|
|
|
12.5
|
|
|||
|
Total long-term care services
|
$
|
145.4
|
|
|
79.5
|
%
|
|
$
|
137.2
|
|
|
81.1
|
%
|
|
$
|
8.2
|
|
|
6.0
|
%
|
|
|
Three Months Ended March 31,
|
|
|
|||||||||||||||||||||||||
|
|
2011
|
`
|
2010
|
|
Increase/(Decrease)
|
|||||||||||||||||||||||
|
|
Revenue
(prior to
intersegment
eliminations)
|
|
Cost of Service
Dollars
(prior to
intersegment
eliminations)
|
|
Revenue Percentage
|
|
Revenue
(prior to
intersegment
eliminations)
|
|
Cost of Service
Dollars
(prior to
intersegment
eliminations)
|
|
Revenue Percentage
|
|
||||||||||||||||
|
|
||||||||||||||||||||||||||||
|
|
Dollars
|
|
Percentage
|
|||||||||||||||||||||||||
|
|
(dollars in millions)
|
|||||||||||||||||||||||||||
|
Rehabilitation therapy services
|
$
|
39.3
|
|
|
$
|
33.3
|
|
|
84.7
|
%
|
|
$
|
33.8
|
|
|
$
|
28.5
|
|
|
84.3
|
%
|
|
$
|
4.8
|
|
|
16.8
|
%
|
|
Total therapy services
|
$
|
39.3
|
|
|
$
|
33.3
|
|
|
84.7
|
%
|
|
$
|
33.8
|
|
|
$
|
28.5
|
|
|
84.3
|
%
|
|
$
|
4.8
|
|
|
16.8
|
%
|
|
|
Three Months Ended March 31,
|
|
|
|||||||||||||||||
|
|
2011
|
|
2010
|
|
Increase/(Decrease)
|
|||||||||||||||
|
|
Cost of Service
Dollars
|
|
Revenue
Percentage
|
|
Cost of Service
Dollars
|
|
Revenue
Percentage
|
|
||||||||||||
|
|
||||||||||||||||||||
|
|
Dollars
|
|
Percentage
|
|||||||||||||||||
|
|
(dollars in millions)
|
|||||||||||||||||||
|
Hospice
|
$
|
10.9
|
|
|
76.2
|
%
|
|
$
|
3.0
|
|
|
96.8
|
%
|
|
$
|
7.9
|
|
|
263.3
|
%
|
|
Home Health
|
3.3
|
|
|
89.2
|
|
|
—
|
|
|
—
|
|
|
3.3
|
|
|
100.0
|
|
|||
|
Total hospice & home health services
|
$
|
14.2
|
|
|
165.4
|
%
|
|
$
|
3.0
|
|
|
96.8
|
%
|
|
$
|
11.2
|
|
|
373.3
|
%
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2011
|
|
2010
|
||||
|
Cash Flows from Continuing Operations
|
|
|
|
||||
|
Net cash provided by operating activities
|
$
|
11,875
|
|
|
$
|
18,138
|
|
|
Net cash used in investing activities
|
(2,517
|
)
|
|
(9,698
|
)
|
||
|
Net cash used in financing activities
|
(12,610
|
)
|
|
(9,861
|
)
|
||
|
Net decrease in cash and cash equivalents
|
(3,252
|
)
|
|
(1,421
|
)
|
||
|
Cash and cash equivalents at beginning of period
|
4,192
|
|
|
3,528
|
|
||
|
Cash and cash equivalents at end of period
|
$
|
940
|
|
|
$
|
2,107
|
|
|
|
Twelve Months Ending March 31,
(3)
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
|
2011
|
|
2012
|
|
2013
|
|
2014
|
|
2015
|
|
Thereafter
|
|
Total
|
|
Fair Value
|
||||||||||||||||
|
Fixed-rate debt
(1)
|
$
|
3,089
|
|
|
$
|
2,153
|
|
|
$
|
2,162
|
|
|
$132,172
(4)
|
|
|
$
|
183
|
|
|
$
|
563
|
|
|
$
|
140,322
|
|
|
$
|
143,901
|
|
|
|
Average interest rate
|
5.2
|
%
|
|
6.0
|
%
|
|
6.0
|
%
|
|
10.9
|
%
|
|
6.0
|
%
|
|
6.0
|
%
|
|
|
|
|
||||||||||
|
Variable-rate debt
(2)
|
$
|
3,600
|
|
|
$
|
3,600
|
|
|
$
|
3,600
|
|
|
$
|
3,600
|
|
|
$
|
17,600
|
|
|
$
|
338,400
|
|
|
$
|
370,400
|
|
|
$
|
370,400
|
|
|
Average interest rate
(3)
|
5.3
|
%
|
|
5.3
|
%
|
|
6.1
|
%
|
|
7.0
|
%
|
|
7.6
|
%
|
|
8.1
|
%
|
|
|
|
|
||||||||||
|
(1)
|
Excludes unamortized original issue discount of $0.3 million on our 11.0% senior subordinated notes.
|
|
(2)
|
Excludes unamortized original issue discount of $2.3 million on our first lien senior secured term loan debt.
|
|
(3)
|
Based on implied forward three-month LIBOR rates in the yield curve as of
March 31, 2011
.
|
|
(4)
|
If the 11% senior subordinated notes remain outstanding on October 14, 2013, then the maturity date of the senior secured credit facility will be October 14, 2013.
|
|
Loan
|
Transaction
Type
|
|
Notional
Amount
|
|
Trade
Date
|
|
Effective
Date
|
|
Maturity/
Termination
Date
|
|
Three months
Ended
March 31, 2011
|
|
Fair Value
(Pre-tax)
|
||||||
|
First Lien
|
cap
|
|
$
|
70,000
|
|
|
6/30/2010
|
|
7/2/2010
|
|
12/31/2011
|
|
$
|
—
|
|
|
$
|
—
|
|
|
First Lien
|
swap
|
|
$
|
70,000
|
|
|
6/30/2010
|
|
1/1/2012
|
|
6/30/2013
|
|
$
|
—
|
|
|
$
|
(298
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
—
|
|
|
$
|
(298
|
)
|
||
|
Period
|
|
Total Number of Shares Purchased
(1)
|
|
Average Price Paid per Share
|
|
Total Number of Shares Purchase as Part of Publicly Announced Plans or Programs
|
|
Maximum Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
|
|||
|
January 1 - 31, 2011
|
|
—
|
|
|
$
|
—
|
|
|
n/a
|
|
n/a
|
|
Feburary 1 - 28, 2011
|
|
53,984
|
|
|
$
|
12.74
|
|
|
n/a
|
|
n/a
|
|
March 1 - 31, 2011
|
|
—
|
|
|
$
|
—
|
|
|
n/a
|
|
n/a
|
|
Total:
|
|
53,984
|
|
|
$
|
12.74
|
|
|
n/a
|
|
n/a
|
|
(a)
|
Exhibits
.
|
|
|
|
|
|
Number
|
|
Description
|
|
|
|
|
|
31.1*
|
|
Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
31.2*
|
|
Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
32**
|
|
Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
SKILLED HEALTHCARE GROUP, INC.
|
|
|
|
|
|
Date:
|
May 3, 2011
|
/s/ Devasis Ghose
|
|
|
|
Devasis Ghose
|
|
|
|
Executive Vice President, Treasurer and Chief Financial Officer
|
|
|
|
(Principal Financial Officer and Authorized Signatory)
|
|
|
|
|
|
|
|
/s/ Christopher N. Felfe
|
|
|
|
Christopher N. Felfe
|
|
|
|
Senior Vice President, Finance and Chief Accounting Officer
|
|
Number
|
|
Description
|
|
|
|
|
|
31.1*
|
|
Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
31.2*
|
|
Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
32**
|
|
Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|